Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2011-01-04
2011-01-04
Chen, Stacy B (Department: 1648)
Chemistry: molecular biology and microbiology
Vector, per se
C424S224100
Reexamination Certificate
active
07863041
ABSTRACT:
Rabies Virus compositions and methods are provided. The full-length sequence of Rabies Virus strain Evelyn-Rokitnicki-Abelseth (ERA) is disclosed. A reverse genetics system for producing recombinant ERA virus and derivatives thereof is provided, along with compositions including ERA and/or ERA derivative strain viruses, nucleic acids and/or proteins. In some instances, the compositions are immunogenic compositions useful for the pre- or post-exposure treatment of Rabies Virus.
REFERENCES:
patent: 4040904 (1977-08-01), Slater
patent: 4393201 (1983-07-01), Curtis et al.
patent: 5695757 (1997-12-01), Rupprecht et al.
patent: 5789229 (1998-08-01), Wert et al.
patent: 6719981 (2004-04-01), Mabatsion et al.
patent: 2002/0131981 (2002-09-01), Dietzschold et al.
patent: 2003/0113346 (2003-06-01), Dietzchold et al.
patent: 2003/0224017 (2003-12-01), Samal et al.
patent: 2004/0208900 (2004-10-01), Fu
patent: 0 702 085 (1996-03-01), None
patent: 0 780 475 (1997-06-01), None
patent: 1 253 197 (2002-10-01), None
patent: 1 394 259 (2004-03-01), None
patent: WO 95/09249 (1995-04-01), None
patent: WO 00/32755 (2000-06-01), None
Wu et al., Glycoprotein gene relocation in rabies virus, Virus Research, 2008, 131:95-99.
Anilionis et al., “Structure of the glycoprotein gene in rabis virus,”Nature, 294:275-278 (1981).
Bridgen et al., “Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs,”Proc. Natl. Acad. Sci. USA, 93:15400-15404 (1996).
Conzelmann et al., “Molecular Cloning and Complete Nucleotide Sequence of the Attenuated Rabies Virus SAD B19,”Virology, 175:485-499 (1990).
Dietzschold et al., “Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus,”Proc. Natl. Acad. Sci., USA80:60-74 (1983).
Dietzschold et al., “New Approaches to the Development of Live Attenuated Rabies Vaccines,”Hybridoma and Hybridomics, 21(2):129-134 (2002).
Dietzschold et al., “New approaches to the prevention and eradication of rabies,”Expert Rev. Vaccines, 2(3):399-406 (2003).
Faber, et al., “Overexpression of the Rabies Virus Glycoprotein Results in Enhancement of Apoptosis and Antiviral Immune Response,”Journal of Virology, 76(7):3374-3381 (2002).
Fodor et al., “Nucleotide and deduced amino acid sequences of the glycoprotein gene of rabies virus vaccine strain Vnukove-32,”Arch. Virol., 135:451-459 (1994).
Gaudin, Yves, “Rabies Virus-induced Membrane Fusion Pathway,”The Journal of Cell Biology, 150(3):601-611 (2000).
Hiramatsu et al., “Comparative Sequence Analysis of the M Gene Among Rabies Virus Strains and its Expression by Recombinant Vaccinia Virus,”Virus Genes, 7(1):83-88 (1993).
Inoue et al., “An improved method for recovering rabies virus from cloned cDNA,”J. Virol. Method., 107, 229-236 (2003).
Ito et al., “A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan,”Microl. Immunol., 38:479-482 (1994).
Ito et al., “Improved Recovery of Rabies Virus from Cloned cDNA Using a Vaccinia Virus-Free Reverse Genetics System,”Microbiol. Immunol., 47(8):613-617 (2003).
Lawson et al., “The ERA Strain of Rabies Vaccine,”Can. J. Comp. Med, 36:339-344 (1972).
Martins et al., “Pathogenesis of rabies virus by ERA and PV strains administered orally in hamsters (M. auratus),”Brazilian Journal of Veterinary Research and Animal Science, 40:79-84 (2003).
McKenna et al., “Recombinant Rhabdoviruses as Potential Vaccines for HIV-1 and Other Diseases,”Current HIV Research, 1:229-237 (2003).
Morimoto et al., “Structure and transcription of the glycoprotein gene of attenuated HEP-Flury strain of rabies virus,”Virol., 173:465-477 (1989).
Rupprecht et al., “The ascension of wildlife rabies: a cause for public health concern or intervention?”Emerg. Infect. Dis., 1(4):107-114 (1995).
Schnell et al., “Polymerase activity of in vitro mutated rabies virus L protein,”Virol., 214:522-530 (1995).
Schnell et al., “The application of reverse genetics technology in the studies of rabies virus (RV) pathogenesis and for the development of novel RV vaccines,”Journal of NeuroVirology, 11:76-81 (2005).
Tordo et al., “Completion of the Rabies Virus Genome Sequence Determination: Highly Conserved Domains among the L (polymerase) Proteins of Unsegmented Negative-Strand RNA Viruses,” Virology, 165:565-576 (1988).
Tuffereau et al., “Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice,”Virology172:206-212 (1989).
Wandeler et al., “Oral immunization of wildlife against rabies: concept and first field experiments,”Rev. Infect. Dis., 10 suppl.4:649-653 (1988).
Wojczyk et al., “The role of site-specific N-glycosylation in secretion of soluble forms of rabies virus glycoprotein,”Glycobiology, 8(2) 121-130 (1998).
Wu et al., “Both Viral Transcription and Replication Are Reduced when the Rabies Virus Nucleoprotein is Not Phosphorylated,”Journal of Virology, 76(9):4153-4161 (2002).
Yamada et al., “Multigenic Relation to the Attenuation of Rabies Virus,”Microbiol. Immunol., 50(1):25-32 (2006).
Fu et al., “Inhibition of Rabies Virus Infection by an Oligodeoxynucleotide Complementary to Rabies Virus Genomic RNA,”Antisense&Nucleic Acid Drug Development, 6:87-93 (1996).
Hemachudha et al., “Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges,”Lancet Neurology, 1:101-109 (2002).
Ito et al., “Rescue of Rabies Virus from Cloned cDNA and Identification of the Pathogenicity-related gene: Glycoprotein Gene is Associated with Virulence for Adult Mice,”Journal of Virology, 75:9121-9128 (2001).
Rupprecht et al., “Oral vaccination of dogs with recombinant rabies virus vaccines,”Virus Research, 111:101-105 (2005).
Rupprecht et al., “Rabies re-examined,”Lancet Infectious Diseases, 2:327-343 (2002).
Schnell et al., “Infectious rabies virus from cloned cDNA,”The EMBO Journal, 13:4195-4203 (1994).
Rupprecht Charles E.
Wu Xianfu
Chen Stacy B
Klarquist & Sparkman, LLP
The United States of America as represented by the Secretary of
LandOfFree
Rabies virus vector systems and compositions and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rabies virus vector systems and compositions and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rabies virus vector systems and compositions and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2692912